Step 1 topics → Reproductive → HSV-2 Genital Herpes

HSV-2 Genital Herpes

USMLE Step 1 trap: Confuses the latency site of HSV-2 with that of HSV-1. HSV-2 establishes latency in the sacral dorsal root ganglia (S2–S4), while HSV-1 latency is in the trigeminal ganglion.

HSV-2 is the most common cause of genital ulcers and shows up on USMLE Step 1 in two main ways: clinical presentation questions that ask you to identify primary vs. recurrent infection, and management questions that test your knowledge of diagnosis and treatment. The virus follows a classic pattern — painful vesicles that ulcerate, systemic symptoms on first exposure, then lifelong latency with periodic reactivation. The key to getting these questions right is understanding the biology behind the clinical pattern, not just memorizing facts.

What makes HSV-2 tricky is that it shares features with HSV-1 and VZV, so the exam loves to test whether you can distinguish between them. Students routinely mix up the latency sites for HSV-1 vs. HSV-2, and they often misread a Tzanck smear result as diagnostic for HSV-2 specifically — it isn't. These are the exact misconceptions that appear in wrong answer choices.

The USMLE Step 1 also tests the reversal of severity between primary and recurrent infection, which is counterintuitive. Students assume that after years of recurrence the body would eventually mount a worse response, but the opposite is true — primary infection is the most severe episode. Nail these three patterns and you'll be set for any HSV-2 question the exam throws at you.

From real student decks
14%have cards covering this topic
14%have mature cards
2median lapses in 14 days

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: HSV-2 establishes latency in the trigeminal ganglion like HSV-1.
Right: HSV-2 establishes latency in the sacral dorsal root ganglia (S2–S4), while HSV-1 latency is in the trigeminal ganglion.
HSV-1 and HSV-2 both establish neuronal latency, but they travel to different ganglia. HSV-1 infects oral/facial mucosa and travels up the trigeminal nerve to the trigeminal ganglion; HSV-2 infects genital mucosa and travels up the sacral sensory nerves to the sacral dorsal root ganglia (S2–S4). This anatomical difference explains why HSV-2 reactivates as genital lesions rather than cold sores. On the exam, if the question mentions genital herpes, the latency site is sacral DRG — full stop.
Common mistake
Wrong: A positive Tzanck smear (multinucleated giant cells) is specific for HSV-2.
Right: Tzanck smear is positive for both HSV and VZV; PCR of lesion fluid is the gold standard for confirming HSV and distinguishing subtypes.
Tzanck smear detects multinucleated giant cells, which are a cytopathic effect of herpesviruses broadly — not HSV-2 specifically. Both HSV-1, HSV-2, and VZV will produce a positive Tzanck. It's a quick bedside test that tells you 'this is a herpesvirus infection,' but it cannot tell you which one. If you need to confirm HSV-2 and distinguish it from VZV or HSV-1, PCR of lesion fluid is the gold standard. Don't let a positive Tzanck in an answer choice trick you into selecting HSV-2-specific diagnosis.
Common mistake
Wrong: Recurrent HSV outbreaks are more severe than the primary episode.
Right: Primary HSV infection is typically more severe (systemic symptoms, extensive lesions, longer duration); recurrences are milder and shorter due to partial immune control.
Primary HSV infection is the worst episode because the immune system has never seen the virus before — there are no pre-existing antibodies or memory T cells to contain it. This leads to widespread vesicles, systemic flu-like symptoms, inguinal lymphadenopathy, and a prolonged course of 2–3 weeks. By the time the virus reactivates, partial immune memory blunts the response, so recurrences produce fewer lesions, no systemic symptoms, and resolve in days. If an exam question describes a severe first episode with systemic features, that's primary infection — not a bad recurrence.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a clinical vignette describing genital ulcers, distinguish primary from recurrent HSV-2 infection based on severity, systemic symptoms, and duration — and identify where the virus hides during latency between outbreaks.
  2. Select the correct diagnostic test for confirming HSV-2 (including when Tzanck smear is vs. isn't useful) and identify the appropriate antiviral treatment and suppression strategy.

Can you avoid these mistakes?

A 24-year-old woman presents with her first episode of painful genital ulcers, fever, and bilateral inguinal lymphadenopathy. Where is HSV-2 establishing latency right now, and what will trigger future reactivation from that site?
A Tzanck smear of a genital vesicle shows multinucleated giant cells. A student concludes this confirms HSV-2 infection. What is wrong with this interpretation, and what test should be ordered instead?
A 30-year-old man with known HSV-2 presents with a mild recurrence of 2–3 genital vesicles with no systemic symptoms. How does this compare pathophysiologically to his initial outbreak 3 years ago, and why is it less severe?
A patient with frequent HSV-2 recurrences (6+ per year) asks about management options. What is the difference between episodic therapy and suppressive therapy, and which antiviral class is used for both?

Related topics

Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →